Skip to main content
. 2023 Aug 20;21:558. doi: 10.1186/s12967-023-04435-6

Fig. 4.

Fig. 4

MR activities and downstream pathway enrichment analysis. A Top MRs specific to INV High/Low phenotype (MR in > 5 out of 10 cancers). B Significantly enriched pathways associated with MRs specific to INV Low. C Significantly enriched pathways associated with MRs specific to INV High